Showing 1 - 19 results of 19 for search 'Rina V. Denisova', query time: 0.06s Refine Results
  1. 1
    THE EXPERIENCE OF SWITCHING TO THE SECOND TNF INHIBITOR IN A PATIENT WITH SEVERE JUVENILE POLYARTHRITIS AND RESISTANCE TO THE FIRST TNF-BLOCKER

    THE EXPERIENCE OF SWITCHING TO THE SECOND TNF INHIBITOR IN A PATIENT WITH SEVERE JUVENILE POLYARTHRITIS AND RESISTANCE TO THE FIRST TNF-BLOCKER by Ekaterina I. Alexeeva, Tatiana M. Dvoryakovskaya, Rina V. Denisova, Olga L. Lomakina, Anna V. Karaseva

    Published 2017-09-01
    Get full text
    Article
  2. 2
    SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL RECOMMENDATIONS. PART 1

    SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL RECOMMENDATIONS. PART 1 by Ekaterina I. Alexeeva, Tatiana M. Dvoryakovskaya, Irina P. Nikishina, Rina V. Denisova, Nadezhda S. Podchernyaeva, Olga A. Sukhorukikh, Lyubov S. Shubina

    Published 2018-04-01
    Get full text
    Article
  3. 3
    Efficacy and Safety of Immunization With Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis: Preliminary Results of a Prospective Open-Label Study

    Efficacy and Safety of Immunization With Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis: Preliminary Results of a Prospective Open-Label Study by Ekaterina I. Alexeeva, Margarita A. Soloshenko, Tatiana M. Dvoryakovskaya, Olga L. Lomakina, Rina V. Denisova, Kseniya B. Isaeva, Anna V. Karasyova

    Published 2017-06-01
    Get full text
    Article
  4. 4
    High Efficiency of Human Normal Immunoglobulin for Intravenous Administration in a Patient with Kawasaki Syndrome Diagnosed in the Later Stages

    High Efficiency of Human Normal Immunoglobulin for Intravenous Administration in a Patient with Kawasaki Syndrome Diagnosed in the Later Stages by Tatyana V. Sleptsova, Ekaterina I. Alekseeva, Тatyana M. Bzarova, Rina V. Denisova, Kseniya B. Isaeva, Margarita A. Soloshenko, Оlga L. Lomakina

    Published 2016-09-01
    Get full text
    Article
  5. 5
    Effect of Monotherapy with Methotrexate, Etanercept and their Combination on the Quality of Life in Children with Early and Late Juvenile Idiopathic Arthritis: A Prospective Study

    Effect of Monotherapy with Methotrexate, Etanercept and their Combination on the Quality of Life in Children with Early and Late Juvenile Idiopathic Arthritis: A Prospective Study by Anna N. Fetisova, Tatyana M. Dvoryakovskaya, Vladislav V. Chernikov, Irina V. Vinyarskaya, Rina V. Denisova, Margarita A. Soloshenko, Ksenia В. Isaeva, Anna V. Mamutova

    Published 2018-10-01
    Get full text
    Article
  6. 6
    Pneumococcal Vaccination of Patients with Juvenile Idiopathic Arthritis: Review of International Experience

    Pneumococcal Vaccination of Patients with Juvenile Idiopathic Arthritis: Review of International Experience by Margarita A. Soloshenko, Ekaterina I. Alekseeva, Tatiana M. Bzarova, Kseniya B. Isaeva, Rina V. Denisova, Olga L. Lomakina, Elena M. Kaschenko, Anna V. Karaseva

    Published 2017-04-01
    Get full text
    Article
  7. 7
    SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL RECOMMENDATIONS. PART 2

    SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL RECOMMENDATIONS. PART 2 by Ekaterina I. Alexeeva, Tatiana M. Dvoryakovskaya, Irina P. Nikishina, Rina V. Denisova, Nadezhda S. Podchernyaeva, Ol’ga A. Sukhorukikh, Lyubov’ S. Shubina, Vyacheslav G. Chasnyk, Mikhail M. Kostik

    Published 2018-05-01
    Get full text
    Article
  8. 8
    EFFICACY AND SAFETY OF RITUXIMAB IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A RETROSPECTIVE STUDY OF THE CASE SERIES

    EFFICACY AND SAFETY OF RITUXIMAB IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A RETROSPECTIVE STUDY OF THE CASE SERIES by Ekaterina I. Alexeeva, Rina V. Denisova, Saniya I. Valieva, Tatyana M. Bzarova, Tatyana V. Sleptsova, Alexandra M. Chomakhidze, Kseniya B. Isayeva, Evgeniya G. Chystyakova, Elena L. Semikina

    Published 2016-11-01
    Get full text
    Article
  9. 9
    EXPERIENCE OF THE SUCCESSFUL CANAKINUMAB TREATMENT OF A PATIENT WITH UNDIFFERENTIATED AUTOINFLAMMATORY SYNDROME

    EXPERIENCE OF THE SUCCESSFUL CANAKINUMAB TREATMENT OF A PATIENT WITH UNDIFFERENTIATED AUTOINFLAMMATORY SYNDROME by Tatyana V. Sleptsova, Еkaterina I. Alexeeva, Тatyana М. Bzarova, Kirill V. Savostyanov, Аlexander A. Pushkov, Kseniya B. Isaeva, Rina V. Denisova, Оlga L. Lomakina

    Published 2016-11-01
    Get full text
    Article
  10. 10
    Experience of Vaccination of a Patient with Systemic Juvenile Idiopathic Arthritis (sJIA) with a 13-Valent Pneumococcal Conjugate Vaccine, prior to the Appointment of Therapy with Tocilizumab, an Anti-IL-6-Receptor Monoclonal Antibody

    Experience of Vaccination of a Patient with Systemic Juvenile Idiopathic Arthritis (sJIA) with a 13-Valent Pneumococcal Conjugate Vaccine, prior to the Appointment of Therapy with... by Daria D. Vankova, Ekaterina I. Alekseeva, Margarita А. Soloshenko, Tatiana М. Dvoriakovskaia, Ksenia B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Mariya G. Rudnitskaya, Nikolay A. Mayansky, Natal’ya Е. Tkachenko

    Published 2018-10-01
    Get full text
    Article
  11. 11
    Pneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review

    Pneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review by Ekaterina I. Alekseeva, Dariya D. Van’kova, Margarita A. Soloshenko, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomahidze, Nikolay A. Mayanskiy, Natalya E. Tkachenko

    Published 2019-06-01
    Get full text
    Article
  12. 12
    Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia

    Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective stud... by Ekaterina I. Alexeeva, Leyla S. Namazova-Baranova, Tatyana M. Bzarova, Saniya I. Valieva, Rina V. Denisova, Tatyana V. Sleptsova, Kseniya B. Isaeva, Alexandra M. Chomahidze, Nikolay I. Taibulatov, Anna N. Fetisova, Anna V. Karaseva, Alexandr A. Baranov

    Published 2017-06-01
    Get full text
    Article
  13. 13
    Early Prognostic Factors for Remission Achievement at Etanercept Therapy in Patients with Juvenile Idiopatic Arthritis Without Systematic Manifestations: Prospective Cohort Study

    Early Prognostic Factors for Remission Achievement at Etanercept Therapy in Patients with Juvenile Idiopatic Arthritis Without Systematic Manifestations: Prospective Cohort Study by Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Dariya D. Vankova, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova

    Published 2019-04-01
    Get full text
    Article
  14. 14
    EFFICACY AND SAFETY OF ETANERCEPT TREATMENT IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS. THE RESULTS OF AN OPEN PROSPECTIVE STUDY ON THE BASIS OF THE SCIENTIFIC CENTER OF CHILDREN'S HEALTH (MOSCOW)

    EFFICACY AND SAFETY OF ETANERCEPT TREATMENT IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS. THE RESULTS OF AN OPEN PROSPECTIVE STUDY ON THE BASIS OF... by Ekaterina I. Alekseeva, Тatyana М. Bzarova, Saniya I. Valieva, Rina V. Denisova, Kseniya B. Isaeva, Evgenia G. Chistyakova, Alexandra M. Chomahidze, Tatyana V. Sleptsova, Anna N. Fetisova, Оlga L. Lomakina, Nikolay I. Taybulatov, Anna V. Karaseva

    Published 2016-11-01
    Get full text
    Article
  15. 15
    13-valent Pneumococcal Conjugate Vaccine and Haemophilus Influenzae-Tetanus Toxoid Conjugate Vaccine in Patient with Systemic Juvenile Idiopathic Arthritis Receiving Tocilizumab: Clinical Case

    13-valent Pneumococcal Conjugate Vaccine and Haemophilus Influenzae-Tetanus Toxoid Conjugate Vaccine in Patient with Systemic Juvenile Idiopathic Arthritis Receiving Tocilizumab: C... by Ekaterina I. Alekseeva, Dar’ya D. Van’kova, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomahidze, Nikolay A. Mayanskiy, Natalya E. Tkachenko, Maria V. Kurdup, Tatyana V. Radygina, Irina V. Zubkova

    Published 2019-09-01
    Get full text
    Article
  16. 16
    PROGNOSTIC FACTORS FOR THE RESPONSE TO TOCILIZUMAB THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS: A COHORT STUDY

    PROGNOSTIC FACTORS FOR THE RESPONSE TO TOCILIZUMAB THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS: A COHORT STUDY by Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Mariya G. Rudnickaya, Dariya D. Vankova, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova

    Published 2018-07-01
    Get full text
    Article
  17. 17
    Immunization With a Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis Without Systemic Manifestations: a Prospective Study

    Immunization With a Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis Without Systemic Manifestations: a Prospective Study by Ekaterina I. Alexeeva, Tatiana M. Dvoryakovskaya, Rina V. Denisova, Ksenia B. Isaeva, Margarita A. Soloshenko, Anna V. Mamutova, Nikolay A. Mayansky, Natalia E. Tkachenko, Irina V. Zubkova, Tatiana A. Kaluzhnaya, Firuza Ch. Shakhtakhtinskaya, Anna G. Gayvoronskaya, Marika I. Broeva, Marina V. Fedoseenko

    Published 2018-01-01
    Get full text
    Article
  18. 18
    Early Predictors of the Response to Adalimumab Therapy in Patients With Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study

    Early Predictors of the Response to Adalimumab Therapy in Patients With Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study by Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Mariya G. Rudnickaya, Dariya D. Vankova, Yuri M. Dyakonov, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova

    Published 2018-12-01
    Get full text
    Article
  19. 19
    Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic Drugs (Tocilizumab or Canakinumab): Prospective Cohort Study

    Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic... by Ekaterina I. Alexeeva, Dariya D. Vankova, Tatyana M. Dvoryakovskaya, Ksenia B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomakhidze, Tatyana V. Radygina, Irina V. Zubkova, Natalia E. Tkachenko, Anna N. Fetisova, Olga L. Lomakina, Yanina O. Orlova, Mariya K. Kurdup, Marina S. Gautier, Elizaveta A. Krekhova, Meyri S. Shingarova, Olga P. Galkina

    Published 2020-08-01
    Get full text
    Article

Search Tools: